ABEOAbeona Therapeutics Inc.
6.090USD-0.65%Mkt Cap: 348.25M $P/E: —3d ago
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy fo…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap348.25M $
Enterprise Value213.86M $
Revenue (TTM)25.52M $
Gross Profit2.40M $
Net Income (TTM)71.18M $
Revenue/Share0.4570 USD
Last Price6.090 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees226
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-32.51
PEG—
EV/EBITDA-2.65
EV/Revenue8.38
P/S13.35
P/B2.66
EPS (TTM)-1.18
EPS (Forward)-0.18
52W Range
4.00057% of range7.650
52W High7.650 USD
52W Low4.000 USD
Profitability
Gross Margin41.15%
Oper. Margin-119.97%
EBITDA Margin0.00%
Profit Margin1223.08%
ROE44.71%
ROA32.42%
Growth
Revenue Growth2745.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-76.33M $
CapEx (TTM)7.97M $
FCF Margin-287.61%
FCF Yield-21.08%
Net Debt-126.95M $
Net Debt/EBITDA1.57
Balance Sheet
Debt/Equity0.16
Current Ratio6.63
Quick Ratio6.32
Book Value/Sh2.238 USD
Cash/Share2.568 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateJul 5, 2022
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)18.86 USD
Upside (mean)+209.6%
Target Range14.00 USD – 28.00 USD
$14.00+209.6% to mean$28.00
# Analysts7
Ownership
Shares Out.57.18M
Float36.80M
Insiders16.49%
Institutions69.74%
Short Interest
Short Ratio10.0d
Short % Float25.69%
Short % Out.23.93%
Shares Short13.64M
Short (prev mo.)13.68M
Technical
SMA 506.339 (-3.9%)
SMA 2005.410 (+12.6%)
Beta1.34
S&P 52W Chg18.16%
Avg Vol (30d)1.61M
Avg Vol (10d)2.32M
Technical Indicators
RSI (14)43.8
MACD-0.0038
MACD Signal0.1157
MACD Hist.-0.1195
BB Upper7.429 USD
BB Middle6.501 USD
BB Lower5.573 USD
BB Width28.53%
ATR (14)0.3889 USD
Vol Ratio (20d)0.54x